Sandoz
Nina Ohara, PharmD, MBA, MS, RPh, currently serves as Executive Director at Coherus BioSciences since February 2022. Prior to this role, Nina held positions at Aerie Pharmaceuticals as Senior Director of Marketing, and at Avanir Pharmaceuticals where responsibilities included Director of Strategic Marketing & Business Operations and Managed Markets Marketing Director. Notable achievements include leading LUMIGAN® 0.01% to become the top branded prostaglandin analog, developing pre-launch reimbursement strategies at Allergan, and directing outcomes research at Eli Lilly and Company. Educational credentials include an MBA in Marketing from USC Marshall School of Business, Master's and Bachelor's degrees in Biochemistry from UCLA, and a PharmD from the University of Southern California.
This person is not in any teams
This person is not in any offices
Sandoz
30 followers
As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people's lives. They contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.